This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Importin 3D structures
From Proteopedia
(Difference between revisions)
| Line 38: | Line 38: | ||
**[[6bvt]] – mIPO NLS-binding domain <br /> | **[[6bvt]] – mIPO NLS-binding domain <br /> | ||
**[[4u5v]], [[4u5u]], [[4u5s]], [[4u5o]], [[4u5n]], [[4u5l]], [[4u58]], [[4u54]] – mIPO NLS-binding domain + inhibitor<br /> | **[[4u5v]], [[4u5u]], [[4u5s]], [[4u5o]], [[4u5n]], [[4u5l]], [[4u58]], [[4u54]] – mIPO NLS-binding domain + inhibitor<br /> | ||
| + | **[[7s1e]] – IPO – guinea pig<br /> | ||
*''IPO-α 1 complex with NLS peptide'' | *''IPO-α 1 complex with NLS peptide'' | ||
| Line 46: | Line 47: | ||
**[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | **[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
**[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | **[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | ||
| + | **[[7n8j]] – hIPO NLS-binding domain + BIMAX peptide<br /> | ||
**[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | ||
**[[4mz5]], [[4mz6]] – mIPO NLS-binding domain 70-528 + dUTPase<br /> | **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain 70-528 + dUTPase<br /> | ||
| Line 56: | Line 58: | ||
**[[5ekg]], [[5ekf]], [[5e6q]] – mIPO NLS-binding domain + XPG2<br /> | **[[5ekg]], [[5ekf]], [[5e6q]] – mIPO NLS-binding domain + XPG2<br /> | ||
**[[5d5k]] – mIPO NLS-binding domain + PARP 2<br /> | **[[5d5k]] – mIPO NLS-binding domain + PARP 2<br /> | ||
| + | **[[7l04]] – mIPO NLS-binding domain + adeno-associated virus<br /> | ||
**[[5ctt]] – mIPO NLS-binding domain + SART3/TIP110<br /> | **[[5ctt]] – mIPO NLS-binding domain + SART3/TIP110<br /> | ||
**[[5b56]] – mIPO NLS-binding domain + HIV-1 VPR<br /> | **[[5b56]] – mIPO NLS-binding domain + HIV-1 VPR<br /> | ||
| Line 66: | Line 69: | ||
**[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | **[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | ||
**[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | **[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | ||
| - | **[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> | + | **[[5u5p]], [[5u5r]], [[6wba]], [[6wbb]], [[6wbc]], [[7m60]] – mIPO NLS-binding domain + MLH1 peptide <br /> |
**[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | **[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | ||
**[[6iw8]], [[6iwa]] – mIPO NLS-binding domain + GM130 peptide <br /> | **[[6iw8]], [[6iwa]] – mIPO NLS-binding domain + GM130 peptide <br /> | ||
| Line 73: | Line 76: | ||
**[[6p6a]] – mIPO NLS-binding domain + NIT-2 peptide <br /> | **[[6p6a]] – mIPO NLS-binding domain + NIT-2 peptide <br /> | ||
**[[6p6e]] – mIPO NLS-binding domain + PAC3 peptide <br /> | **[[6p6e]] – mIPO NLS-binding domain + PAC3 peptide <br /> | ||
| - | **[[7jk7]] – mIPO NLS-binding domain + LSD1 peptide <br /> | + | **[[7jjm]], [[7jk7]] – mIPO NLS-binding domain + LSD1 peptide <br /> |
| + | **[[7jvo]] – mIPO NLS-binding domain + ACE2 peptide <br /> | ||
| + | **[[7rg4]], [[7rg5]] – mIPO NLS-binding domain + p50 peptide <br /> | ||
| + | **[[6wx7]] – mIPO NLS-binding domain + SOX2 peptide <br /> | ||
**[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | ||
**[[4b8p]] – rIPO NLS-binding domain + A89<br /> | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | ||
| Line 120: | Line 126: | ||
**[[3fex]], [[3fey]] – mIPO NLS-binding domain + nuclear CAP-binding protein<br /> | **[[3fex]], [[3fey]] – mIPO NLS-binding domain + nuclear CAP-binding protein<br /> | ||
| + | **[[7rfx]], [[7rfz]], [[7rg0]], [[7rg1]], [[7rg2]], [[7rg3]], [[7rg6]] – mIPO + ORF4b<br /> | ||
*IPO-α 3 | *IPO-α 3 | ||
| Line 129: | Line 136: | ||
**[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | **[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | ||
**[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | **[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | ||
| + | **[[7rfy]] – hIPO + ORF4b<br /> | ||
| + | **[[6wx8]] – hIPO + SOX2<br /> | ||
| + | |||
| + | *IPO-α 5 | ||
| + | |||
| + | **[[6wx9]] – hIPO + SOX2<br /> | ||
*IPO-α 6 | *IPO-α 6 | ||
| Line 151: | Line 164: | ||
**[[1qgx]], [[1qgk]] – hIPO + IPO-α 2 IBB domain<br /> | **[[1qgx]], [[1qgk]] – hIPO + IPO-α 2 IBB domain<br /> | ||
**[[1ibr]] – hIPO + GTPase Ran<br /> | **[[1ibr]] – hIPO + GTPase Ran<br /> | ||
| - | **[[ | + | **[[6n88]], [[6n89]] – hIPO + H1.0 – Cryo EM<br /> |
**[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | **[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | ||
**[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | **[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | ||
**[[2p8q]], [[2q5d]], [[2qna]], [[3lww]] – hIPO + RNA U transporter N terminal<br /> | **[[2p8q]], [[2q5d]], [[2qna]], [[3lww]] – hIPO + RNA U transporter N terminal<br /> | ||
**[[1qgr]], [[3w5k]] – hIPO + zinc finger protein SNAI1<br /> | **[[1qgr]], [[3w5k]] – hIPO + zinc finger protein SNAI1<br /> | ||
| - | **[[5owu]] – yIPO + Nup1<br /> | ||
**[[1ukl]] – mIPO + SREBP-2<br /> | **[[1ukl]] – mIPO + SREBP-2<br /> | ||
| + | **[[2bku]], [[3ea5]] – yIPO + GTPase Ran<br /> | ||
| + | **[[5owu]] – yIPO + Nup1<br /> | ||
*IPO-β 2 (Transportin 1) | *IPO-β 2 (Transportin 1) | ||
Revision as of 07:38, 3 October 2021
3D structures of importin
Updated on 03-October-2021
